pmid,title,journal,year,drug,disease
39024368,"In-silico discovery of common molecular signatures for which SARS-CoV-2 infections and lung diseases stimulate each other, and drug repurposing.",PloS one,2024,Nilotinib,Tuberculosis
38701094,Mycobacterium tuberculosis resides in lysosome-poor monocyte-derived lung cells during chronic infection.,PLoS pathogens,2024,Nilotinib,Tuberculosis
37398178,Mycobacterium tuberculosis resides in lysosome-poor monocyte-derived lung cells during chronic infection.,Research square,2023,Nilotinib,Tuberculosis
36711606,Mycobacterium tuberculosis resides in lysosome-poor monocyte-derived lung cells during chronic infection.,bioRxiv : the preprint server for biology,2023,Nilotinib,Tuberculosis
31795474,PP2Ac Modulates AMPK-Mediated Induction of Autophagy in Mycobacterium bovis-Infected Macrophages.,International journal of molecular sciences,2019,Nilotinib,Tuberculosis
31309096,First case report of latent tuberculosis reactivation complicating treatment with nilotinib in chronic myeloid leukemia.,Blood research,2019,Nilotinib,Tuberculosis
31130711,Nilotinib: A Tyrosine Kinase Inhibitor Mediates Resistance to Intracellular Mycobacterium Via Regulating Autophagy.,Cells,2019,Nilotinib,Tuberculosis
28753128,Imatinib-Induced Interstitial Pneumonitis Successfully Switched to Nilotinib in a Patient with Prior History of Mycobacterium tuberculosis Infection.,Turkish journal of haematology : official journal of Turkish Society of Haematology,2017,Nilotinib,Tuberculosis
24351780,Off-Target Effects of BCR-ABL and JAK2 Inhibitors.,American journal of clinical oncology,2016,Nilotinib,Tuberculosis
